CHINA PHARMA HOLDINGS, INC. (CPHI) Net margin 2016–2025
CHINA PHARMA HOLDINGS, INC. (CPHI) net profit margin by fiscal year — reported net income divided by reported revenue.
-76.9%FY2025 · since FY2016: -59.0% → -76.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -76.9% | +27.7 pp |
| FY2024 | -104.6% | -60.7 pp |
| FY2023 | -43.9% | +5.1 pp |
| FY2022 | -49.0% | -13.8 pp |
| FY2021 | -35.3% | -8.9 pp |
| FY2020 | -26.4% | +163.1 pp |
| FY2019 | -189.5% | -102.3 pp |
| FY2018 | -87.2% | +58.7 pp |
| FY2017 | -145.9% | -86.9 pp |
| FY2016 | -59.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice